Pivalolactone: Target Organs and Levels of Evidence for TR-140
Bioassay of Pivalolactone for Possible Carcinogenicity (CASRN 1955-45-9)
| Chemical (Study Title) CASRN |
Peer Review Date | Route/Exposure Levels | Study Laboratory |
|---|---|---|---|
| Pivalolactone 1955-45-9 |
06/29/1978 | Gavage R: 0,150,300, M: 0,75,150 MG/KG/50 PER GROUP |
Litton Bionetics, Inc. |
Levels of Evidence
Male Rats: Positive
| Type | Organ/Tissue (Lesion) |
|---|---|
| Neoplastic Lesions |
|
Female Rats: Positive
| Type | Organ/Tissue (Lesion) |
|---|---|
| Neoplastic Lesions |
|